CEO Salary & Executive Compensation
West Pharmaceutical WST
CEO: Eric Green · Pharmaceutical Packaging · 10,500 employees
Eric Green, CEO of West Pharmaceutical (WST), earned $8.0M in total compensation in 2025. West Pharmaceutical receives a Pay-for-Performance grade of A (86/100), with a CEO-to-worker pay ratio of 107:1 and a say-on-pay shareholder approval of 90.7%. The company's 3-year total shareholder return is +33.9%.
How West Pharmaceutical CEO Pay Compares
Eric Green's $8.0M total compensation is 0% below the Pharmaceutical Packaging industry median of $8.0M. The 107:1 CEO-to-worker pay ratio is 0% lower than the industry average of 107:1.
West Pharmaceutical (WST) disclosed $8.0M in CEO compensation for Eric Green. The package is structured for retention plus performance alignment, with equity awards taking the largest share.
The CEO-to-median-worker pay ratio runs 107x. Lower ratios typically reflect companies with higher-paid workforces (financial services, technology, professional services) where the median worker pay denominator is itself substantial. Performance has been positive over the three-year window: TSR of 33.9% alongside 16.0% revenue growth. Compensation packages tied to relative TSR or absolute return benchmarks would have vested at or near target levels with this performance profile.
Shareholders supported the compensation package at 91% on the most recent say-on-pay vote. Solid support without overwhelming endorsement is the typical pattern for established public companies with conventional compensation programs. West Pharmaceutical operates in Pharmaceutical Packaging with 10,500 employees and $2.9B in annual revenue, and currently carries a market capitalization of $24.0B. Pay comparisons across companies require controlling for these structural factors — a $20M package at a $10B-revenue tech company reads differently than the same package at a $1B-revenue industrial.
Source: SEC EDGAR — DEF 14A proxy statements for West Pharmaceutical (WST).
Compensation Breakdown
Eric Green's $8.0M total compensation package for fiscal year 2025 includes $800K in base salary, $4.0M in stock awards, $960K in option awards, and $1.2M in bonus and non-equity incentives.
Compensation History
| Year | Salary | Bonus | Stock Awards | Options | Non-Equity | Other | Total |
|---|---|---|---|---|---|---|---|
| 2025 | $800K | - | $4.0M | $960K | $1.2M | $880K | $8.0M |
| 2024 | $800K | - | $4.0M | $960K | $1.2M | $880K | $8.0M |
| 2023 | $800K | - | $4.0M | $960K | $1.2M | $880K | $8.0M |
| 2022 | $800K | - | $4.0M | $960K | $1.2M | $880K | $8.0M |
All compensation data is sourced from SEC DEF 14A proxy filings submitted to EDGAR. The Economic Policy Institute's CEO pay analysis provides additional context on executive compensation trends across industries.
Named Executive Officers
Eric Green, CEO of West Pharmaceutical (WST), earns $8.0M in total compensation. This includes base salary, stock awards, option awards, and other incentives as reported in the company's most recent DEF 14A proxy statement.
Frequently Asked Questions
Eric Green, CEO of West Pharmaceutical (WST), earns $8.0M in total compensation. This includes base salary, stock awards, option awards, and other incentives as reported in the company's most recent DEF 14A proxy statement.
West Pharmaceutical has a Pay-for-Performance Score of A (86/100). The company's 3-year total shareholder return is +33.9%, and the say-on-pay shareholder vote passed with 90.7% approval.
The CEO-to-median-worker pay ratio at West Pharmaceutical is 107:1. The median worker at West Pharmaceutical earns $75K per year, while CEO Eric Green earns $8.0M in total compensation.
West Pharmaceutical employs approximately 10,500 people. The company operates in the Pharmaceutical Packaging industry within the Healthcare sector, generating $2.9B in annual revenue.